Advertisement

Breast Cancer Research and Treatment

, Volume 15, Issue 3, pp 205–212 | Cite as

Host heterogeneity in female breast cancer: Possible significance for pathophysiology, therapy, and prevention

  • Philip Cohen
Hypothesis

Summary

Longitudinal studies on human growth have revealed seasonal patterns in the gain of height in 1/3 of the population. Seasonal sensitivity of growth velocity is apparently linked with a lean body structure. This being so, a subgroup with specific biological features could be isolated, including specific endocrine mechanisms (e.g. shorter interval between menarche and menopause, higher incidence of irregular early postmenstrual cycles, and higher concentration of growth hormone secretion) and specific metabolic pathways (more frequent drinking, smoking, and use of the contraceptive pill). This biological specificity may be responsible for behavioral heterogeneity in cancer in general and in breast malignancies in particular. One third of the breast cancer patient population is hormone responsive. The response to all the methods of cancer adjuvant therapy (including ablation of hormone producing organs, chemotherapy, and immunologic manipulation) used up till now does not surpass 33% in the long run. Breast cancer risk reduction by 1/3 due to full-term teenage pregnancies suggests that this may be a consequence of the interruption of a premalignant process initiated in women of the aforementioned subgroup. Simulation of early pregnancy might therefore lead to prevention of breast cancer in women who had seasonal growth patterns as children.

Key words

adjuvant therapy body mass index chemotherapy response endocrine mechanisms hormone response host heterogeneity leanness melatonin rhythm reproductive factors seasonal growth 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Borms J, Hauspie R, Sand A, Susannc C, Hebbelinck M (eds): Human Growth and Development. Plenum Press, New York, 1984Google Scholar
  2. 2.
    Tanner JM: Growth at Adolescence (1st and 2d ed). Blackwell, Oxford, 1955, 1962Google Scholar
  3. 3.
    Tanner JM: Human growth and constitution.In: Harrison GA, Weiner JS, Tanner JM, Barnicot NA (eds) Human Biology. Oxford University Press, London, 1964, pp 299–366Google Scholar
  4. 4.
    Marshall WA: The relationship of variations in childrens' growth rates to climatic variations. Ann Hum Biol 2: 243–250, 1975Google Scholar
  5. 5.
    Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE: Moderate alcohol consumption and the risk of breast cancer. N Engl J Med 316: 1174–1180, 1987PubMedGoogle Scholar
  6. 6.
    Vandenbroucke JP, van Laar A, Valkenburg HA: Thinness, delayed menarche, and irregular cycles. N Engl J Med 305: 229–230, 1981Google Scholar
  7. 7.
    Cohen P: Genetic heterogeneity in control mechanisms of human reproduction: significance for isolation of patient subgroups.In: Hayes DK, Pauly JE, Reiter RJ (eds): Clinical Application of Chronobiology. Proc 19th Conf Int Soc Chronobiol, June 20–24 1989 (In press)Google Scholar
  8. 8.
    Lund E: Reproductive histories and premenopausal breast cancer: different estimates using population, neighborhood, or hospital controls. Cancer Res 49: 4015–4019, 1989PubMedGoogle Scholar
  9. 9.
    Sherman B, Wallace R, Schlabaugh L: Relationship of body weight to menarcheal and menopausal age: implications for breast cancer risk. J Clin Endocrinol Metab 52: 488–493, 1981PubMedGoogle Scholar
  10. 10.
    Devi MR, Kumari JR, Srikumari CR: Fertility and mortality differences in relation to maternal body size. Ann Hum Biol 12: 479–484, 1985PubMedGoogle Scholar
  11. 11.
    Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO: Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64: 51–58, 1987PubMedGoogle Scholar
  12. 12.
    Schatzkin A, Jones DY, Hoover RN, Taylor PR, Brinton LA, Ziegler RG, Harvey EB, Carter CL, Licitra LM, Dufour MC, Larson DB: Alcohol consumption and breast cancer in the epidemiologic follow-up study of the First National Health and Nutritional Examination Survey. N Engl J Med 316: 1169–1173, 1987PubMedGoogle Scholar
  13. 13.
    Willett WC, Stampfer MJ, Bain C, Lipnick R, Speizer F, Rosner B, Cramer D, Hennekens CH: Cigarette smoking, relative weight and menopause. Am J Epidemiol 117: 651–658, 1983PubMedGoogle Scholar
  14. 14.
    Wallace RB, Heiss G, Burrows B, Graves K: Contrasting diet and body mass among users and nonusers of oral contraceptives and exogenous estrogens: the Lipid Research Clinics Program Prevalence Study. Am J Epidemiol 125: 854–859, 1987PubMedGoogle Scholar
  15. 15.
    Pfaffenberger RS, Kampert JB, Chang H-G: Characteristics that predict risk of breast cancer before and after menopause. Am J Epidemiol 112: 258–268, 1980PubMedGoogle Scholar
  16. 16.
    Willett WC, Browne MI, Bain C, Lipnick RJ, Stampfer MJ, Rosner B, Colditz GA, Hennekens CH, Speizer FE: Relative weight and risk of breast cancer among premenopausal women. Am J Epidemiol 122: 731–740, 1983Google Scholar
  17. 17.
    Lippman ME, Dickson EB, Gelmann EP, Knappe C, Kasid A, Bates S, Swain S: Mechanisms of estrogenic and anti-estrogenic regulation of growth of human breast carcinoma.In: Klein JMG (ed) Hormonal Manipulation of Cancer: Peptides, Growth Factors, and New (Anti)steroidal Agents. Raven Press, New York, 1985, pp 381–406Google Scholar
  18. 18.
    McMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravinhar B, Salber EJ, Valaoras VG, Yuasa S: Age at first birth and cancer of the breast. A summary of an international study. Bull WHO 43: 209–221, 1970PubMedGoogle Scholar
  19. 19.
    Bonadonna G, Valagussa P: The contribution of medicine to primary treatment of breast cancer. Cancer Res 48: 2314–2324, 1988PubMedGoogle Scholar
  20. 20.
    Anderson DE: Familial and genetic predisposition.In: Stoll BA (ed) Risk Factors in Breast Cancer. William Heineman Medical Books, London, 1976, pp 1–24Google Scholar
  21. 21.
    Seltzer MH, Plato CC, Engler PE, Fletcher HS: Digital dermatoglyphics and breast cancer. Breast Cancer Res Treat 2: 261–265, 1982PubMedGoogle Scholar
  22. 22.
    Lissoni P, Tancini G, Barni S, Crispino S, Paolorossi F, Cattaneo G, Fraschini F: Melatonin increase as predictor for tumor objective response to chemotherapy in advanced cancer patients. Tumori 74: 339–345, 1988PubMedGoogle Scholar
  23. 23.
    Rosenberg SA, Lotze MT, Muul IM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DEA: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316: 889–897, 1987PubMedGoogle Scholar
  24. 24.
    Schatzkin A, Hoover RN, Taylor R, Ziegler RG, Carter CL, Albanes D, Larson DB, Licitra LM: Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Cancer Res 48: 452–458, 1988PubMedGoogle Scholar
  25. 25.
    McNamara DJ, Kolb R, Parker TS, Batwin H, Samuel P, Brown CD, Ahrens EH: Heterogeneity of cholesterol homeostasis in man. Response to changes in dietary fat quality and cholesterol quantity. J Clin Invest 79: 1729–1739, 1987PubMedGoogle Scholar
  26. 26.
    Gordon DJ, Trost DC, Hyde J, Whaley FS, Hannan PJ, Jacobs DR, Ekelund LG: Seasonal cholesterol cycles: the Lipid Research Clinics Coronary Primary Prevention Trial placebo group. Circulation 76: 1224–1231, 1987PubMedGoogle Scholar
  27. 27.
    Cohen P, Wax Y, Modan B: Seasonality in the occurrence of breast cancer. Cancer Res 43: 892–896, 1983PubMedGoogle Scholar
  28. 28.
    Kirkham N, Machin D, Cotton DKW, Pike JM: Seasonality and breast cancer. Eur J Surg Oncol 11: 143–146, 1985PubMedGoogle Scholar
  29. 29.
    Mason BH, Holdaway IM, Mullins PR, Kay RG, Skinner SJ: Seasonal variation in breast cancer detection: correlation with tumor progesterone receptor status. Breast Cancer Res Treat 5: 171–176, 1985PubMedGoogle Scholar
  30. 30.
    Ownby HE, Frederick J, Mortensen RF, Ownby DR, Russo J: Seasonal variation in tumor size and immunological responses in human breast cancer. Invasion Metastasis 6: 246–256, 1986PubMedGoogle Scholar
  31. 31.
    Lubin F, Ruder A, Wax Y, Modan B: Overweight and changes in weight throughout adult life in breast cancer etiology: a case control study. Am J Epidemiol 122: 579–588, 1985PubMedGoogle Scholar
  32. 32.
    Hislop TG, Goldman AJ, Elwood JM, Brauer G, Kan L: Childhood and recent eating patterns and risk of breast cancer. Cancer Detect Prev 9: 47–58, 1986PubMedGoogle Scholar
  33. 33.
    LeMarchand L, Kolonel LN, Earle ME, Mi M-P: Body size at different periods of life and breast cancer risk. Am J Epidemiol 128: 137–152, 1988PubMedGoogle Scholar
  34. 34.
    Malarkey WB, Schroeder LL, Stevens VA, James AG, Lanese RR: Disordered nocturnal prolactin regulation in women with breast cancer. Cancer Res 37: 4650–4654, 1977PubMedGoogle Scholar
  35. 35.
    Phillips HJ, Wilson DW, Simpson HW, Fahmy DR, Groom GV, Phillips ME, Pierrepoint CG, Blamey RW, Halberg F, Griffiths K: Characterisation of breast skin temperature rhythms of women in relation to menstrual status. Acta Endocrinol 96: 350–360, 1981PubMedGoogle Scholar
  36. 36.
    Cecchettin M, Cavallini V, Natali G, Benvenuti M, Torcia M, Tarquini B: Calcitonin in a chronobiological perspective. Chronobiologia 10: 115–116, 1983 (Abstract)Google Scholar
  37. 37.
    Rønnike F: Seasonal conception by women in various age groups compared with the season of menarche. Dan Med Bull 28: 148–153, 1981PubMedGoogle Scholar
  38. 38.
    Fisher B, Fisher ER, Redmond C, and Participating NSABP Investigators: Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of 1-phenalanine mustard (1-PAM) in the management of primary breast cancer. J Clin Oncol 4: 929–941, 1986PubMedGoogle Scholar
  39. 39.
    Buzdar AU, Hortobagyi GN, Kau S-W, Smith TL, Fraschini G, Holmes FA, Hug V, Campos LT, Amas LT, Martin RG: Breast cancer adjuvant therapy trials of M.D. Anderson Hospital: results of three studies.In: Salmon SE (ed) Adjuvant Therapy of Cancer, V. Grune and Stratton, Orlando, 1987, pp 411–418Google Scholar
  40. 40.
    Bryant AJS, Weir JA: Prophylactic oophorectomy in operable instances of carcinoma of the breast. Surg Gynecol Obstet 153: 660–664, 1981PubMedGoogle Scholar
  41. 41.
    Padmanabhan N, Howell A, Rubens RD: Mechanisms of action of adjuvant chemotherapy in early breast cancer. Lancet ii: 411–414, 1986Google Scholar
  42. 42.
    Danforth DN, Tamarkin L, Mulvihill JJ, Bagley CS, Lippman ME: Plasma melatonin and the hormone-dependency of human breast cancer. J Clin Oncol 3: 941–948, 1985PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1990

Authors and Affiliations

  • Philip Cohen
    • 1
  1. 1.Kiryat TivonIsrael

Personalised recommendations